SCM
LUXAW

Saba Capital Management’s Lux Health Tech Acquisition Corp. Warrants LUXAW Stock Holding History

Saba Capital Management’s Portfolio LUXAW Stock Details LUXAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-149,858
Closed -$20K – 1169
2022
Q3 		$20K Hold
149,858
– – ﹤0.01% 949
2022
Q2 		$22K Hold
149,858
– – ﹤0.01% 996
2022
Q1 		$62K Buy
+149,858
New +$85.1K ﹤0.01% 852

Saba Capital Management's LUXAW Position: Q4 2022 in Review

Saba Capital Management sold out of Lux Health Tech Acquisition Corp. Warrants (LUXAW) in Q4 2022, closing a stake of 149,858 shares — an estimated $20K sold.

Saba Capital Management first reported a position in LUXAW in Q1 2022 and held it in 3 quarters. The position peaked at $62K in Q1 2022. 0 funds tracked by Wall St. Rank hold LUXAW as of Q4 2022.

  • Saba Capital Management reported no remaining Lux Health Tech Acquisition Corp. Warrants position as of Q4 2022 after selling out during the quarter.
  • Saba Capital Management sold 149,858 Lux Health Tech Acquisition Corp. Warrants shares in Q4 2022, an estimated $20K.
  • Saba Capital Management first reported a position in Lux Health Tech Acquisition Corp. Warrants in Q1 2022 and held it in 3 quarters.
  • Saba Capital Management's Lux Health Tech Acquisition Corp. Warrants position peaked at $62K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Warrants as of Q4 2022.

Based on Saba Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.